logo
  

Burberry Names Jonathan Akeroyd CEO, Executive Director, Effective April 1

Burberry Group plc (BRBY.L) announced Wednesday the appointment of Jonathan Akeroyd as Chief Executive Officer and Executive Director, effective April 1, 2022.

He will succeed Marco Gobbetti as Burberry Chief Executive Officer. Marco will step down from the role and leave Burberry on 31 December 2021. Gerry Murphy will chair the Executive Committee from this date until Akeroyd joins Burberry.

He will report to Chair Murphy and the Board of Directors.

Akeroyd, 54, is currently Chief Executive Officer of Milan-based Gianni Versace SpA, a position he has held since June 2016.

He was previously Chief Executive Officer of Alexander McQueen from 2004 to 2016, during which time he led a turnaround of the British luxury brand and laid the foundation for global expansion.

He has also held a number of senior fashion roles at London-based luxury department store Harrods.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
Follow RTT